{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:22:08Z","timestamp":1787671328426,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Phenylephrine (PE) is currently the vasopressor of choice to prevent and treat spinal-induced hypotension at cesarean delivery (CD). However, its use is often associated with reflex bradycardia. Norepinephrine (NE) has been put forward as an alternative vasopressor during CD due to its ability to treat hypotension while maintaining heart rate (HR). Recent studies have focused on the role of NE used as an infusion with favorable results compared to PE. No studies have compared equipotent bolus doses of PE and NE at CD. We hypothesized that when used in equipotent doses as an intermittent bolus regimen to prevent and treat spinal-induced hypotension, NE would result in a reduction in the incidence of bradycardia compared to PE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This was a double-blind, randomized clinical trial of women undergoing elective CD under spinal anesthesia. Women were randomized to receive either PE 100 \u00b5g or NE 6 \u00b5g when the systolic blood pressure (SBP) was below baseline. In addition to the randomized treatment, ephedrine was given intravenously to both groups if the SBP was below baseline and the HR &lt;60 bpm or if the SBP was &lt;80% of baseline for 2 consecutive readings. The primary outcome was bradycardia (HR &lt;50 bpm) in the predelivery period. Secondary outcomes included hypotension (SBP &lt;80% of baseline), hypertension (SBP &gt;120% of baseline), tachycardia (HR &gt;120% of baseline), \u22652 episodes of bradycardia, nausea, vomiting, umbilical artery and vein blood gases, and Apgar scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      One hundred twelve patients were randomized. The incidence of bradycardia was lower in the NE group compared to the PE group (10.7% vs 37.5%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001; difference [95% confidence interval {CI}], \u221226.8% [\u221241.8% to \u221211.7%]), implying an estimated 71% relative reduction (95% CI, 35%\u201388%). The distribution of the number of bradycardia episodes was also different between the 2 groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .007). Further testing showed that the patients in the PE group had a higher risk of multiple bradycardia episodes (\u22652 episodes) compared to the NE group (19.6% for PE versus 3.6% for NE;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .008). The proportion of patients requiring rescue boluses of ephedrine was lower in the NE group compared to the PE group (7.2% for NE versus 21.4% for PE;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .03; difference [95% CI], \u221214.3% [\u221227.0% to \u22121.6%]). No differences were observed between the 2 groups in the incidence of other secondary outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>When used as an intermittent bolus regimen to prevent and treat spinal-induced hypotension during CD, NE resulted in a significant reduction in the incidence of bradycardia as compared to an equipotent bolus regimen of PE. We conclude that the hemodynamic profile offered by NE during CD is superior to that of PE due to less fluctuations in HR and possibly cardiac output.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000003704","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T21:59:14Z","timestamp":1534370354000},"page":"1312-1318","source":"Crossref","is-referenced-by-count":93,"title":["Comparison of Intermittent Intravenous Boluses of Phenylephrine and Norepinephrine to Prevent and Treat Spinal-Induced Hypotension in Cesarean Deliveries: Randomized Controlled Trial"],"prefix":"10.1213","volume":"129","author":[{"given":"Aidan M.","family":"Sharkey","sequence":"first","affiliation":[{"name":"Department of Anesthesia and Pain Management, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Pain Management, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Downey","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Pain Management, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang Y.","family":"Ye","sequence":"additional","affiliation":[{"name":"Maternal-Infant Care Research Center, Mount Sinai Hospital, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Guevara","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Pain Management, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C. A.","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Pain Management, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/AIA.0b013e31802b8d53","article-title":"Obstetric anesthesia controversies: vasopressor choice for postspinal hypotension during cesarean delivery.","volume":"45","author":"Macarthur","year":"2007","journal-title":"Int Anesthesiol Clin"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/00000539-200204000-00028","article-title":"A quantitative, systematic review of randomized controlled trials of ephedrine versus phenylephrine for the management of hypotension during spinal anesthesia for cesarean delivery.","volume":"94","author":"Lee","year":"2002","journal-title":"Anesth Analg"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1213\/ANE.0b013e31826ac3db","article-title":"Phenylephrine infusion versus bolus regimens during cesarean delivery under spinal anesthesia: a double-blind randomized clinical trial to assess hemodynamic changes.","volume":"115","author":"Doherty","year":"2012","journal-title":"Anesth Analg"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/ALN.0000000000000601","article-title":"Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery.","volume":"122","author":"Ngan Kee","year":"2015","journal-title":"Anesthesiology"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1213\/ANE.0000000000001846","article-title":"Norepinephrine to prevent hypotension during spinal anesthesia for cesarean delivery: a sequential allocation dose finding study.","volume":"125","author":"Onwochei","year":"2017","journal-title":"Anesth Analg"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejogrb.2015.07.001","article-title":"Determination of the 90% effective dose (ED90) of phenylephrine for hypotension during elective cesarean delivery using a continual reassessment method.","volume":"194","author":"Liu","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/bmj.296.6632.1313","article-title":"Statistics in medicine: calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates.","volume":"296","author":"Morris","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/ALN.0b013e3181b437e0","article-title":"Hemodynamic effects of ephedrine, phenylephrine, and the coadministration of phenylephrine with oxytocin during spinal anesthesia for elective cesarean delivery.","volume":"111","author":"Dyer","year":"2009","journal-title":"Anesthesiology"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/ALN.0b013e31818a401f","article-title":"Continuous invasive blood pressure and cardiac output monitoring during cesarean delivery: a randomized, double-blind comparison of low-dose versus high-dose spinal anesthesia with intravenous phenylephrine or placebo infusion.","volume":"109","author":"Langesaeter","year":"2008","journal-title":"Anesthesiology"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/ACO.0b013e32834588c5","article-title":"Maternal haemodynamic changes during spinal anaesthesia for caesarean section.","volume":"24","author":"Langes\u00e6ter","year":"2011","journal-title":"Curr Opin Anaesthesiol"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/bja\/aeh088","article-title":"Comparison of phenylephrine infusion regimens for maintaining maternal blood pressure during spinal anaesthesia for caesarean section.","volume":"92","author":"Ngan Kee","year":"2004","journal-title":"Br J Anaesth"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/CRD.0b013e31824e2294","article-title":"Vasopressor use in adult patients.","volume":"20","author":"Ferguson-Myrthil","year":"2012","journal-title":"Cardiol Rev"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"S455","DOI":"10.1097\/01.CCM.0000142909.86238.B1","article-title":"Vasopressor and inotropic support in septic shock: an evidence-based review.","volume":"32","author":"Beale","year":"2004","journal-title":"Crit Care Med"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jemermed.2017.09.007","article-title":"Complications from administration of vasopressors through peripheral venous catheters: an observational study.","volume":"54","author":"Medlej","year":"2018","journal-title":"J Emerg Med"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/ALN.0000000000001880","article-title":"A random-allocation graded dose-response study of norepinephrine and phenylephrine for treating hypotension during spinal anesthesia for cesarean delivery.","volume":"127","author":"Ngan Kee","year":"2017","journal-title":"Anesthesiology"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000003704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:22:02Z","timestamp":1786112522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000003704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000003704","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}